Cargando…
Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers.
Germline mutations of the BRCA2 gene on chromosome 13q12-q13 predispose to the development of early-onset breast cancer and ovarian cancer. Loss of heterozygosity detected using chromosome 13q markers in the vicinity of BRCA2 is observed in most cancers arising in carriers of germline BRCA2 mutation...
Autores principales: | Collins, N., Wooster, R., Stratton, M. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228118/ https://www.ncbi.nlm.nih.gov/pubmed/9365162 |
Ejemplares similares
-
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016) -
Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter
por: Poli, Elizabeth, et al.
Publicado: (2015) -
Complete Profiling of Methyl-CpG-Binding Domains for Combinations of Cytosine Modifications at CpG Dinucleotides Reveals Differential Read-out in Normal and Rett-Associated States
por: Buchmuller, Benjamin C., et al.
Publicado: (2020) -
DEAF1 Binds Unmethylated and Variably Spaced CpG Dinucleotide Motifs
por: Jensik, Philip J., et al.
Publicado: (2014) -
Less is more: Biased loss of CpG dinucleotides strengthens antiviral immunity
por: Sauter, Daniel, et al.
Publicado: (2021)